Why the study?
Due to the very low incidence of retroperitoneal sarcomas and management dependent on anatomical characteristics and histotype, clinical recommendations were needed to guide diagnosis, treatment, and follow-up.
This paper provides updated clinical recommendations from the Spanish Sarcoma Research Group (GEIS) for the multidisciplinary management of retroperitoneal sarcomas.
Soft tissue sarcomas (STS) are an uncommon and biologically heterogeneous group of tumors arising from mesenchymal cells. The incidence is estimated at five cases per 100,000 people per year. Retroperitoneal sarcomas (RPS) account for 10-15% of all STS, and their management depends on their anatomical characteristics and histotype. Due to their very low incidence, it is recommended that RPS be treated in reference centers and evaluated by an experienced multidisciplinary team (MDT). In Spain, the Spanish Group for Research in Sarcomas (GEIS) brings together experts from various specialties to promote research on sarcomas and improve treatment results. This paper summarizes the GEIS recommendations for the diagnosis, treatment, and follow-up of patients with RPS.
No takes yet. Share an insight, caveat, or question.
Álvarez et al. (2023) conducted a review in Retroperitoneal Sarcoma. Clinical recommendations was evaluated. The Spanish Sarcoma Research Group (GEIS) provides updated clinical recommendations for the multidisciplinary diagnosis, treatment, and follow-up of patients with retroperitoneal sarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: